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Young I nvestigator | N ews & A nalysis

Michelle J Yoo
Position
Graduate Research Assistant
Research area
Bioanalytical chemistry and separations

Supervisor’s supporting
comments

I have always been impressed with Michelle’s ability
to conduct research in an independent and yet
highly effective manner. Part of her research in my
group has examined the use of affinity columns to
examine drug–protein binding with serum proteins,
University of Nebraska, Department of Chemistry, Hamilton Hall 705, Lincoln,
NE 68588, USA
such as human serum albumin. This work is
Tel.: +1 402 472 9402
Fax: +1 402 472 6956
extremely important to the fields of pharmaceutical
E-mail: myoo@huskers.unl.edu
chemistry and clinical chemistry in providing the
data needed for the development of new drugs or
in the optimization of treatments for patients with new, or existing, drugs. Another topic that Michelle has examined
in her research is the use of new supports based on monolithic materials and ultrafast-extraction methods for
affinity-based separations of biological samples and high-throughput screening of drug–protein binding. She was
the lead author on a review written on this topic and also has several research publications related to this area of
work. During her graduate studies, Michelle has emerged as a real leader in my group. She has excellent people
and communication skills and is highly motivated in her pursuit of an advanced degree in analytical chemistry and
bioanalysis. I have extremely high expectations for her in the future as she continues her career.
Nominated by: David S Hage, University of Nebraska, Department of Chemistry, Hamilton Hall 704, Lincoln, NE 68588, USA

QQ What drove you to choose a career
in bioanalysis?
The biological interactions that occur within
the body have been a topic of interest to me
since beginning my coursework as a graduate
student. There are many interactions, such as
the binding between drugs and proteins, which
are important in everyday life. Through my
graduate research experiences in an analytical
chemistry laboratory, I was further interested in
the use of analytical techniques to characterize
these interactions in a quantitative manner. A
career in bioanalysis allows me to research topics
that are more biologically related and use analytical methods to measure the extent of these
interactions in the same environment.
QQ Describe the main highlights of your
bioanalytical research, and its importance to
the bioanalytical community both now and
in the future.
My research focus is to develop microaffinity columns for use in high-performance
affinity chromatography that can be applied
towards the creation of new approaches for
high-throughput anal ysis of drug–protein

interactions. Microaffinity columns can analyze these interactions on a much smaller timescale (minutes to seconds). With the use of
materials such as silica monoliths, I can analyze
drug–protein interactions on a much smaller
time scale (milliseconds) by using higher flow
rates with silica monoliths while immobilizing
ligands using similar chemistry schemes as with
particle-based supports.
My research has also shown that traditional
longer columns, used in high-performance
affinity chromatography, can be replaced with
much shorter columns (from cm to mm) to
reduce analysis times even further. One application of shorter columns is the ultrafast-affinity
extraction for free-drug fraction analysis. This
involves using a short column to rapidly extract
the free-drug fraction of a drug by taking into
account the short time required to separate the
free and protein-bound drug fractions. This is
also requires the avoidance of any errors due to
the dissociation of drug–protein complexes as
they pass through the column. These advancements can play a role in the transition to their
use in a clinical setting where shorter analysis
times are needed.
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QQ Where do you see your career in
bioanalysis taking you?
From my experiences with studying biologically related interactions and using analytical
techniques, especially high-performance affinity
chromatography, I have developed a great interest
in examining other biological systems and using
this knowledge to aid in the research and development of new pharmaceutical agents. I would like
to continue working in the field of rapid analysis
and high-throughput screening of drug candidates by using different types of support materials
and taking advantage of the many different available techniques, such as CE and MS. In addition
to using other methods, I envision my career in
bioanalysis incorporating the high-throughput
settings into a clinical environment, where rapid
analysis times are desired. I see a big part of my
career to include working with others, whether it
is through collaborations, training or teaching.
I will strive to constantly learn something from
each person I work with and hope to relay a part
of my knowledge to that person as well.
QQ How do you envisage the field of
bioanalysis evolving in the future?
I see the field of bioanalysis as constantly emerging with newer, improved techniques and mat
erials, which, I believe, will help bring about
more novel ideas and research, especially in areas
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that tie together biology, analytical chemistry
and biochemistry. I envisage these new developments will bring more research that can perform
analyses with fewer amounts of sample requirements and faster analysis times. With the ongoing research pointing in the direction of more
analyses performed in a high-throughput setting,
I hope that the transition into a clinical setting
will more quickly arise. I also see more research
conducted through collaborations from several
different experts in the fields of biology, chemistry
and biochemistry, in addition to those in medical
research fields. The research conducted by each
expert will only aid in more successful progress
to attain the eventual goal of the research study.
With more experts from different areas working
together, I believe that the field of bioanalysis
will grow quickly and strongly over time as more
experts contribute to this field and as technology
continues to improve.
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Bioanalysis Young Investigator Award –
sponsored by Waters

Each issue of Bioanalysis features a Young Investigator profile, where young
bioanalysts have the opportunity to describe their work and future aspirations. At the end of each year a winner will be selected by the editorial
advisory board and will be presented with a $1000 award, sponsored by
Waters. A travel fund is provided by Waters to assist with the cost of travel
to the award ceremony.
For a young scientist, being recognized for your hard work at such an early
stage in your career is a tremendous honor.
Young Investigators should be early career researchers, including Masters
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and Doctorate students, PostDoctorate researchers and those working
in industry.
If you wish to nominate a Young Investigator, please contact the Editor
for more details.
Ryan De Vooght-Johnson, Junior Managing Commissioning Editor
Future Science Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK
Tel.: +44 (0)20 8371 6090
Fax: +44 (0)20 8343 2313
E-mail: r.devooght-johnson@future-science.com
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